The vaccine market is becoming an increasingly strategic component of preventive healthcare as governments, healthcare organizations, and pharmaceutical companies continue to prioritize immunization, outbreak preparedness, and long-term disease prevention. The market was valued at USD 72.8 billion in 2025 and is estimated to reach USD 78.1 billion in 2026, before expanding to USD 115.8 billion...
0 Commentarios
0 Acciones
840 Views
0 Vista previa